Bilateral disease is somewhat more common in patients with infiltrating lobular carcinoma.

Even though lobular carcinoma in situ can't spread, it is important to keep an eye on the condition.

Breast cancer samples show loss of Sulf1 expression in invasive lobular carcinomas.

Most women who are diagnosed with lobular carcinoma in situ have not yet gone through menopause.

Lobular carcinoma in situ is most commonly diagnosed after a biopsy.

Lobular carcinoma in situ usually has no symptoms.

Invasive lobular carcinoma accounts for 5-10% of invasive breast cancer.

The majority of women with lobular carcinoma in situ will not need immediate treatment with surgery or medicines.

Lobular carcinoma is a form of tumor which primarily affects the lobules of a gland.

Loss of E-cadherin is common in lobular carcinoma but is also seen in other breast cancers.

Presence of lobular carcinoma in situ.

Women with some forms of very early breast cancer, such as ductal or lobular carcinoma in situ, do not need lymph node testing.

Lobular carcinoma in situ (LCIS) is the other type of stage 0 cancer.

Treatment of lobular carcinoma in situ (LCIS) may include the following:

The term lobular carcinoma in situ (LCIS) is misleading.

Most of the risk relates to subsequent invasive ductal carcinoma rather than to invasive lobular carcinoma.

"Breast cancers like invasive lobular carcinomas can masquerade as normal, even if you can feel them," Dr. Homer said.

The overall 5-year survival rate for both invasive ductal carcinoma and invasive lobular carcinoma was approximately 85% in 2003.

Inflammatory carcinoma and Paget disease of the nipple have also been seen in men, but lobular carcinoma in situ has not.

Lobular carcinoma in situ (LCIS).

Infiltrating (invasive) lobular carcinoma (ILC).

Lobular carcinoma in situ, or LCIS, she explained, is an indicator that I was at high risk to develop an invasive breast cancer.

"Finally, one of my biopsies revealed a lobular carcinoma in situ, a kind of precancer that my doctor explained may never become an invasive, serious cancer.